Complete Filing Data
Fulgent Genetics, Inc. reported Net Income Loss of -$60.51 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Fulgent Genetics, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$60.5M | -$42.7M | -$167.8M | $143.4M | $507.4M | $214.3M | -$411.0K | -$5.6M | -$2.5M | -$5.3M | -$8.3M | -$4.3M |
| Revenue * | $322.7M | $283.5M | $289.2M | $619.0M | $992.6M | $421.7M | $32.5M | $21.4M | $18.7M | $18.3M | $9.6M | $1.3M |
| Selling And Marketing Expense | $43.4M | $36.2M | $41.5M | $38.9M | $24.4M | $15.0M | $5.9M | $4.7M | $4.2M | $2.5M | $2.7M | $581.0K |
| Research And Development Expense | $53.9M | $48.8M | $41.4M | $28.9M | $24.2M | $11.6M | $6.5M | $5.5M | $4.2M | $3.6M | $4.4M | $521.0K |
| Operating Income Loss | -$91.1M | -$73.9M | -$195.5M | $178.5M | $676.0M | $290.2M | -$428.0K | -$5.1M | -$3.5M | $918.0K | -$5.0M | -$990.0K |
| Operating Expenses | $222.0M | $181.1M | $300.0M | $188.4M | $101.1M | $41.7M | $18.8M | $15.7M | $13.7M | $10.6M | $9.5M | $1.3M |
| Gross Profit | $130.9M | $107.2M | $104.5M | $366.9M | $777.1M | $331.9M | $18.4M | $10.7M | $10.2M | $11.6M | $4.5M | $342.0K |
| General And Administrative Expense | $116.7M | $88.1M | $89.0M | $111.1M | $50.7M | $15.2M | $6.4M | $5.5M | $5.2M | $4.6M | $2.4M | $230.0K |
| Cost Of Revenue | $191.8M | $176.3M | $184.8M | $252.1M | $215.5M | $89.8M | $14.1M | $10.7M | $8.6M | $6.7M | $5.1M | $936.0K |
| Income Tax Expense Benefit | -$8.4M | -$8.1M | $1.2M | $42.1M | $174.8M | $72.5M | $43.0K | $36.0K | -$1.0M | $920.0K | $0.00 | $0.00 |
| Income Loss From Continuing Operations Per Diluted Share | -$1.97 | -$1.41 | -$5.63 | $4.63 | $16.38 | $8.91 | -$0.02 | -$0.31 | ||||
| Income Loss From Continuing Operations Per Basic Share | -$1.97 | -$1.41 | -$5.63 | $4.76 | $17.25 | $9.44 | -$0.02 | -$0.31 | ||||
| Other Comprehensive Income Loss Net Of Tax | $7.8M | -$1.7M | $23.5M | -$22.6M | -$1.1M | $292.0K | $181.0K | $9.0K | $59.0K | -$103.0K | ||
| Comprehensive Income Net Of Tax | -$52.6M | -$44.3M | -$145.7M | $123.3M | $506.2M | $214.6M | -$230.0K | -$5.6M | -$2.5M | -$5.5M | -$8.3M | -$4.3M |
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | $7.0M | -$1.2M | $24.7M | -$19.9M | -$1.5M | $272.0K | $198.0K | $53.0K | -$22.0K | -$103.0K | ||
| Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax | $775.0K | -$511.0K | -$1.2M | -$2.7M | $456.0K | $20.0K | -$17.0K | -$44.0K | $81.0K | |||
| Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments | $291.7M | $409.0K | -$4.6M | -$3.0M | -$4.5M | |||||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$70.0M | -$52.0M | -$174.1M | $184.0M | $677.3M | $291.7M | $409.0K | -$4.5M | -$5.0M | -$990.0K | ||
| Income Loss From Equity Method Investments | -$488.0K | -$777.0K | -$935.0K | -$524.0K | $0.00 | |||||||
| Income Taxes Paid | $27.6M | $3.3M | $56.2M | $237.1M | $20.6M | $20.0K | $1.0K | $757.0K | $550.0K | |||
| Net Income Loss Attributable To Noncontrolling Interest | -$1.1M | -$1.1M | -$7.4M | -$1.5M | -$1.1M | |||||||
| Deferred Income Tax Expense Benefit | -$1.2M | -$3.7M | $11.5M | -$8.3M | -$8.2M | -$1.8M | -$21.0K | $36.0K | -$336.0K | $246.0K | ||
| Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | -$53.8M | -$45.5M | -$151.7M | $119.3M | $505.1M | $214.6M | -$230.0K | |||||
| Income Loss Before Equity In Net Income Loss Of Investee | $366.0K | -$4.7M | -$2.0M | -$5.4M | ||||||||
| Amortization Of Intangible Assets | $8.0M | $8.0M | $7.8M | $6.5M | $1.7M | |||||||
| Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Noncontrolling Interest | -$87.0K | -$142.0K | $1.4M | -$2.5M | $105.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 | Q3 2016 | Q2 2016 | Q1 2016 | Q4 2015 | Q3 2015 | Q2 2015 | Q1 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$6.6M | -$19.0M | -$11.5M | -$14.6M | -$8.7M | -$13.5M | -$13.1M | -$11.2M | -$15.3M | -$23.8M | $1.7M | $11.5M | $154.0M | $104.3M | $122.5M | $79.8M | $200.7M | $166.3M | $46.6M | $3.3M | -$2.0M | -$296.0K | $1.5M | $331.0K | -$1.9M | -$2.1M | -$595.0K | -$1.0M | -$1.9M | -$1.6M | -$1.1M | -$25.0K | $232.0K | $813.0K | -$1.1M | -$4.5M | -$602.0K | -$7.3M | $1.2M | $747.0K | $425.0K |
| Revenue * | $84.1M | $81.8M | $73.5M | $71.7M | $71.0M | $64.5M | $84.7M | $67.9M | $66.2M | $67.7M | $105.7M | $125.3M | $320.3M | $251.7M | $227.9M | $153.6M | $359.4M | $295.0M | $101.7M | $17.3M | $7.8M | $8.4M | $10.3M | $8.4M | $5.4M | $5.7M | $5.6M | $5.4M | $4.7M | $4.3M | $4.5M | $4.6M | $5.3M | $5.9M | $5.0M | $4.0M | $3.4M | $2.9M | $2.9M | $2.2M | $1.6M |
| Selling And Marketing Expense | $11.6M | $12.3M | $8.5M | $9.1M | $8.6M | $9.0M | $10.2M | $10.7M | $10.1M | $10.3M | $9.9M | $10.9M | $7.9M | $8.2M | $6.0M | $5.2M | $5.0M | $5.1M | $5.0M | $3.3M | $1.6M | $1.6M | $1.7M | $1.3M | $1.3M | $1.1M | $1.1M | $1.3M | $1.1M | $1.1M | $1.4M | $851.0K | $891.0K | $798.0K | $893.0K | $477.0K | $301.0K | $1.9M | $280.0K | $243.0K | $234.0K |
| Research And Development Expense | $13.9M | $13.5M | $12.4M | $11.8M | $13.5M | $11.4M | $10.0M | $9.7M | $9.8M | $8.5M | $7.5M | $6.9M | $6.0M | $7.5M | $6.0M | $5.3M | $5.4M | $4.6M | $3.2M | $1.8M | $2.0M | $1.8M | $1.7M | $1.6M | $1.4M | $1.4M | $1.4M | $1.2M | $1.5M | $1.3M | $1.1M | $920.0K | $851.0K | $818.0K | $1.5M | $656.0K | $561.0K | $3.7M | $312.0K | $252.0K | $217.0K |
| Operating Income Loss | -$15.4M | -$19.7M | -$19.8M | -$17.1M | -$18.9M | -$21.8M | $214.0K | -$19.8M | -$24.8M | -$36.6M | $352.0K | $12.8M | $201.9M | $150.9M | $159.3M | $98.9M | $266.9M | $225.9M | $63.5M | $2.6M | -$1.9M | -$409.0K | $1.5M | $295.0K | -$1.8M | -$1.0M | -$846.0K | -$1.0M | -$2.2M | -$2.1M | -$1.5M | -$150.0K | $219.0K | $1.3M | -$695.0K | $970.0K | -$615.0K | -$7.3M | $1.2M | $747.0K | $405.0K |
| Operating Expenses | $50.9M | $54.1M | $48.1M | $43.9M | $45.4M | $43.9M | $39.6M | $40.4M | $43.6M | $49.5M | $45.7M | $52.5M | $40.6M | $38.7M | $25.1M | $18.9M | $18.4M | $17.3M | $11.9M | $6.9M | $5.6M | $5.2M | $5.0M | $4.5M | $4.2M | $3.9M | $3.9M | $3.9M | $4.1M | $3.8M | $3.7M | $2.9M | $3.2M | $2.7M | $3.6M | $1.6M | $2.8M | $7.5M | $807.0K | $663.0K | $530.0K |
| Gross Profit | $35.5M | $34.4M | $28.3M | $26.8M | $26.5M | $22.1M | $39.8M | $20.6M | $18.8M | $13.0M | $46.1M | $65.3M | $242.5M | $189.5M | $184.4M | $117.8M | $285.4M | $243.2M | $75.5M | $9.5M | $3.7M | $4.8M | $6.5M | $4.8M | $2.4M | $2.9M | $3.0M | $2.9M | $1.9M | $1.7M | $2.2M | $2.8M | $3.4M | $4.0M | $2.9M | $2.6M | $2.1M | $175.0K | $2.0M | $1.4M | $935.0K |
| General And Administrative Expense | $23.3M | $26.4M | $25.3M | $21.0M | $21.3M | $21.5M | $17.5M | $18.0M | $21.8M | $28.8M | $26.3M | $30.2M | $25.8M | $22.1M | $12.3M | $8.3M | $8.0M | $7.6M | $3.7M | $1.8M | $2.0M | $1.7M | $1.5M | $1.6M | $1.5M | $1.4M | $1.3M | $1.4M | $1.5M | $1.4M | $1.2M | $1.1M | $1.5M | $1.1M | $1.1M | $457.0K | $1.9M | $2.0M | $215.0K | $168.0K | $79.0K |
| Cost Of Revenue | $48.6M | $47.4M | $45.1M | $45.0M | $44.5M | $42.4M | $44.8M | $47.3M | $47.4M | $54.7M | $59.6M | $60.1M | $77.7M | $62.1M | $43.5M | $35.9M | $74.1M | $51.8M | $26.3M | $7.7M | $4.1M | $3.6M | $3.9M | $3.6M | $3.0M | $2.8M | $2.6M | $2.5M | $2.8M | $2.5M | $2.3M | $1.9M | $1.9M | $1.9M | $2.1M | $1.4M | $1.3M | $2.7M | $918.0K | $772.0K | $653.0K |
| Income Tax Expense Benefit | -$683.0K | -$2.3M | $176.0K | -$3.8M | -$2.1M | -$327.0K | $20.3M | -$3.1M | -$5.2M | -$9.4M | $414.0K | $2.7M | $48.4M | $47.1M | $37.5M | $23.6M | $66.5M | $58.6M | $14.5M | -$599.0K | $34.0K | -$38.0K | $61.0K | $7.0K | $13.0K | $888.0K | -$318.0K | -$100.0K | -$434.0K | -$596.0K | -$415.0K | -$110.0K | $106.0K | $503.0K | $417.0K | $0.00 | $0.00 | $0.00 | |||
| Income Loss From Continuing Operations Per Diluted Share | -$0.21 | -$0.62 | -$0.37 | -$0.48 | -$0.29 | -$0.45 | -$0.44 | -$0.38 | -$0.52 | -$0.80 | $0.06 | $0.37 | $4.93 | $3.34 | $3.93 | $2.59 | $6.52 | $6.16 | $1.98 | $0.14 | -$0.09 | -$0.01 | $0.08 | $0.02 | -$0.10 | -$0.11 | -$0.03 | -$0.06 | -$0.11 | -$0.06 | $0.00 | $0.01 | -$0.44 | -$0.66 | -$0.05 | ||||||
| Income Loss From Continuing Operations Per Basic Share | -$0.21 | -$0.62 | -$0.37 | -$0.48 | -$0.29 | -$0.45 | -$0.44 | -$0.38 | -$0.52 | -$0.80 | $0.06 | $0.38 | $5.09 | $3.48 | $4.13 | $2.74 | $6.96 | $6.55 | $2.11 | $0.15 | -$0.09 | -$0.01 | $0.08 | $0.02 | -$0.10 | -$0.11 | -$0.03 | -$0.06 | -$0.11 | -$0.06 | $0.00 | $0.01 | -$0.44 | -$0.66 | -$0.05 | ||||||
| Other Comprehensive Income Loss Net Of Tax | $856.0K | $1.4M | $4.7M | $10.3M | $201.0K | -$2.4M | $3.8M | -$4.1M | $5.5M | -$4.4M | -$10.3M | -$11.6M | $28.0K | -$39.0K | -$654.0K | -$442.0K | $1.2M | -$339.0K | -$24.0K | $108.0K | $130.0K | $25.0K | $5.0K | -$43.0K | -$18.0K | ||||||||||||||||
| Comprehensive Income Net Of Tax | -$5.8M | -$17.3M | -$6.8M | -$4.6M | -$8.5M | -$15.8M | -$9.3M | -$14.8M | -$11.6M | -$1.5M | $1.6M | $142.2M | $122.6M | $79.8M | $200.0M | $46.2M | $4.6M | -$2.3M | $1.4M | $439.0K | -$1.8M | -$570.0K | -$1.0M | -$2.0M | -$1.0M | -$8.0K | $214.0K | -$1.1M | -$4.5M | -$543.0K | |||||||||||
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | $742.0K | $1.2M | $4.6M | $9.5M | $312.0K | -$2.1M | $4.0M | -$2.1M | $5.3M | -$2.5M | -$8.5M | -$11.7M | $142.0K | -$75.0K | -$654.0K | -$460.0K | $1.2M | -$336.0K | -$7.0K | $122.0K | $115.0K | $48.0K | $48.0K | -$65.0K | $10.0K | $17.0K | -$18.0K | ||||||||||||||
| Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax | $114.0K | $233.0K | $109.0K | $718.0K | -$111.0K | -$333.0K | -$230.0K | -$2.0M | $168.0K | -$1.9M | -$1.9M | $123.0K | -$114.0K | $36.0K | $18.0K | $2.0K | -$3.0K | -$17.0K | -$14.0K | $15.0K | -$23.0K | -$43.0K | $22.0K | $68.0K | |||||||||||||||||
| Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments | $159.8M | $99.5M | $267.2M | $226.5M | $63.9M | $2.9M | -$1.7M | -$160.0K | $1.7M | $487.0K | -$1.6M | -$931.0K | -$703.0K | -$903.0K | -$2.1M | -$2.0M | -$1.3M | -$30.0K | $338.0K | $1.3M | -$690.0K | -$4.5M | -$602.0K | ||||||||||||||||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$7.5M | -$21.5M | -$11.7M | -$18.5M | -$11.2M | -$14.2M | $6.9M | -$14.7M | -$21.0M | -$33.5M | $1.8M | $13.8M | $202.0M | $150.8M | $159.8M | $99.5M | $267.2M | $226.5M | $63.9M | $2.9M | -$1.7M | $338.0K | $1.3M | -$690.0K | -$4.5M | -$602.0K | -$7.3M | $1.2M | $747.0K | $425.0K | |||||||||||
| Income Loss From Equity Method Investments | $143.0K | -$189.0K | -$193.0K | -$249.0K | -$174.0K | -$175.0K | -$149.0K | -$279.0K | -$234.0K | -$210.0K | -$246.0K | -$245.0K | -$247.0K | -$172.0K | -$105.0K | $0.00 | $0.00 | $0.00 | |||||||||||||||||||||||
| Income Taxes Paid | $54.0K | $1.3M | $1.7M | $435.0K | $33.0K | ||||||||||||||||||||||||||||||||||||
| Net Income Loss Attributable To Noncontrolling Interest | -$218.0K | -$299.0K | -$369.0K | -$46.0K | -$380.0K | -$384.0K | -$359.0K | -$361.0K | -$509.0K | -$244.0K | -$376.0K | -$438.0K | -$422.0K | -$662.0K | -$298.0K | -$165.0K | |||||||||||||||||||||||||
| Deferred Income Tax Expense Benefit | -$133.0K | -$557.0K | -$5.2M | -$5.5M | -$786.0K | -$434.0K | |||||||||||||||||||||||||||||||||||
| Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | -$6.0M | -$17.8M | -$7.2M | -$4.4M | -$8.9M | -$16.3M | -$9.7M | -$15.7M | -$10.4M | -$3.1M | $753.0K | $141.9M | $122.3M | $79.6M | $200.0M | $46.2M | $4.6M | ||||||||||||||||||||||||
| Income Loss Before Equity In Net Income Loss Of Investee | $200.7M | $3.5M | -$1.7M | -$122.0K | $1.6M | $480.0K | -$1.6M | -$1.8M | -$385.0K | -$803.0K | -$1.7M | -$1.4M | -$921.0K | $80.0K | $232.0K | $813.0K | -$1.1M | -$4.5M | -$602.0K | ||||||||||||||||||||||
| Amortization Of Intangible Assets | $2.0M | $2.0M | $2.0M | $2.0M | $2.0M | $2.0M | $2.0M | $2.0M | $2.0M | $2.0M | $2.0M | $1.6M | $906.0K | $911.0K | $797.0K | ||||||||||||||||||||||||||
| Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Noncontrolling Interest | $31.0K | -$237.0K | $30.0K | $200.0K | -$24.0K | -$98.0K | -$68.0K | -$547.0K | $1.8M | -$1.2M | -$422.0K | $119.0K | -$25.0K | $10.0K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $1.11B | $1.13B | $1.14B | $1.27B | $1.16B | $569.4M | $82.8M | $51.2M | $54.2M | $54.5M | $5.1M | $1.7M | $2.0M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $50.3M | $55.3M | $97.5M | $79.5M | $164.9M | $87.4M | $12.0M | $6.7M | $6.5M | ||||
| Allowance For Doubtful Accounts Receivable | $21.4M | $20.5M | $25.2M | $41.2M | $11.2M | $1.9M | $751.0K | $590.0K | $287.0K | $151.0K | $75.0K | $27.0K | |
| Cash And Cash Equivalents At Carrying Value | $50.2M | $55.1M | $97.5M | $79.5M | $164.9M | $87.4M | $12.0M | $6.7M | $7.9M | $489.0K | |||
| Retained Earnings Accumulated Deficit | $530.0M | $590.5M | $633.2M | $801.0M | $657.6M | $150.9M | -$63.4M | -$63.0M | -$57.7M | -$55.2M | -$53.2M | ||
| Property Plant And Equipment Net | $112.5M | $105.5M | $83.5M | $81.4M | $62.3M | $40.2M | $6.0M | $6.4M | $7.3M | $6.2M | $2.5M | ||
| Other Assets Current | $22.6M | $23.0M | $32.6M | $48.9M | $22.5M | $40.4M | $2.3M | $2.6M | $2.4M | $906.0K | $314.0K | ||
| Liabilities Current | $85.0M | $72.9M | $73.0M | $88.1M | $105.3M | $130.1M | $3.7M | $2.7M | $3.0M | $3.3M | $686.0K | ||
| Liabilities And Stockholders Equity | $1.21B | $1.22B | $1.24B | $1.39B | $1.28B | $700.5M | $88.8M | $53.9M | $57.2M | $58.0M | $5.8M | ||
| Liabilities | $106.8M | $90.8M | $102.0M | $116.2M | $112.8M | $131.1M | $6.0M | $2.8M | $3.0M | $3.6M | $686.0K | ||
| Assets Current | $550.5M | $353.6M | $507.8M | $627.9M | $612.0M | $523.6M | $37.1M | $39.5M | $32.9M | $26.1M | $2.9M | ||
| Assets | $1.21B | $1.22B | $1.24B | $1.39B | $1.28B | $700.5M | $88.8M | $53.9M | $57.2M | $58.0M | $5.8M | ||
| Accounts Receivable Net Current | $84.8M | $69.0M | $51.1M | $52.7M | $138.9M | $183.9M | $6.6M | $5.9M | $4.0M | $4.4M | $2.1M | ||
| Accounts Payable Current | $18.7M | $18.4M | $15.4M | $23.1M | $20.5M | $26.5M | $1.6M | $1.3M | $2.1M | $2.8M | $314.0K | ||
| Common Stock Value | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $2.0K | $2.0K | $2.0K | $2.0K | |||
| Other Assets Noncurrent | $22.9M | $33.5M | $34.9M | $44.1M | $10.7M | $4.1M | $251.0K | $17.0K | $39.0K | $17.0K | |||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $7.5M | -$368.0K | $1.2M | -$20.9M | -$759.0K | $438.0K | $146.0K | -$35.0K | -$44.0K | -$103.0K | |||
| Accrued Liabilities Current | $34.1M | $24.3M | $30.7M | $25.0M | $17.7M | $8.4M | $1.3M | $1.3M | $911.0K | $436.0K | $199.0K | ||
| Additional Paid In Capital Common Stock | $574.5M | $543.1M | $501.7M | $486.6M | $501.9M | $418.1M | $146.1M | $114.2M | $111.9M | $109.7M | |||
| Gain Loss On Disposition Of Assets | $3.0K | -$320.0K | -$305.0K | -$502.0K | -$850.0K | -$672.0K | -$11.0K | -$88.0K | -$5.0K | $20.0K | |||
| Other Liabilities Noncurrent | $7.6M | $7.0M | $15.1M | $18.2M | $6.8M | $582.0K | $14.0K | $6.0K | $2.0K | ||||
| Available For Sale Securities Debt Securities Noncurrent | $369.3M | $570.4M | $423.6M | $326.6M | $485.0M | $132.5M | $41.9M | $6.4M | $14.9M | ||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$5.0M | -$42.2M | $18.0M | -$85.4M | $77.5M | $75.5M | $5.2M | $246.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $1.13B | $1.12B | $1.13B | $1.14B | $1.13B | $1.13B | $1.26B | $1.26B | $1.26B | $1.28B | $1.30B | $1.31B | $1.04B | $912.7M | $801.6M | $187.0M | $87.0M | $81.4M | $82.8M | $54.5M | $51.1M | $50.0M | $52.6M | $52.6M | $53.0M | $55.3M | $55.7M | $55.3M | $17.2M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $117.8M | $88.0M | $67.4M | $58.2M | $65.1M | $54.7M | $84.1M | $58.3M | $66.2M | $168.8M | $138.8M | $353.1M | $214.9M | $100.5M | $151.5M | $53.0M | $2.4M | $9.3M | $20.5M | $9.2M | $5.3M | $8.5M | ||||||||
| Allowance For Doubtful Accounts Receivable | $21.5M | $21.4M | $20.9M | $25.3M | $25.3M | $25.8M | $29.1M | $33.2M | $38.3M | $35.4M | $30.3M | $22.1M | $6.9M | $6.0M | $3.9M | $1.2M | $864.0K | $862.0K | $611.0K | $585.0K | $588.0K | $516.0K | $516.0K | $335.0K | $138.0K | $133.0K | $151.0K | $48.0K | ||
| Cash And Cash Equivalents At Carrying Value | $117.6M | $87.9M | $67.3M | $58.0M | $65.1M | $54.7M | $84.1M | $58.3M | $66.2M | $168.8M | $138.8M | $353.1M | $214.9M | $100.5M | $151.5M | $53.0M | $2.4M | $9.3M | $20.5M | $9.2M | $5.3M | $8.5M | $3.7M | $5.3M | $6.5M | $9.5M | $11.5M | $6.7M | ||
| Retained Earnings Accumulated Deficit | $553.4M | $560.0M | $578.9M | $596.4M | $611.0M | $619.7M | $761.3M | $774.4M | $785.7M | $824.8M | $823.1M | $811.6M | $553.3M | $430.7M | $350.9M | -$15.4M | -$62.1M | -$65.4M | -$63.1M | -$64.6M | -$64.9M | -$61.0M | -$60.4M | -$59.3M | -$56.0M | -$54.9M | -$54.9M | -$56.0M | ||
| Property Plant And Equipment Net | $111.9M | $110.2M | $107.1M | $106.8M | $93.4M | $86.7M | $85.3M | $87.6M | $79.1M | $81.8M | $86.0M | $68.6M | $60.2M | $51.1M | $47.0M | $17.4M | $6.0M | $5.7M | $6.4M | $5.9M | $6.0M | $6.9M | $7.3M | $6.9M | $6.5M | $6.7M | $5.9M | $5.2M | ||
| Other Assets Current | $60.4M | $58.6M | $25.0M | $56.2M | $30.8M | $28.8M | $32.8M | $35.0M | $32.7M | $21.4M | $26.5M | $20.0M | $32.0M | $34.3M | $32.9M | $30.0M | $6.4M | $3.3M | $1.8M | $2.3M | $2.3M | $2.4M | $2.5M | $2.6M | $2.4M | $1.7M | $1.2M | $4.9M | ||
| Liabilities Current | $72.4M | $71.3M | $65.9M | $74.0M | $75.8M | $75.9M | $61.4M | $64.8M | $81.9M | $102.5M | $127.5M | $141.7M | $147.2M | $121.5M | $196.5M | $57.7M | $6.5M | $5.8M | $4.3M | $2.9M | $3.2M | $2.3M | $3.0M | $2.4M | $3.2M | $2.8M | $3.3M | $5.0M | ||
| Liabilities And Stockholders Equity | $1.21B | $1.20B | $1.21B | $1.23B | $1.23B | $1.23B | $1.36B | $1.35B | $1.38B | $1.41B | $1.46B | $1.47B | $1.20B | $1.05B | $999.1M | $247.3M | $95.9M | $89.3M | $61.1M | $56.4M | $55.7M | $54.8M | $55.5M | $55.4M | $58.7M | $58.8M | $58.8M | $22.8M | ||
| Liabilities | $93.8M | $88.2M | $83.0M | $98.9M | $103.4M | $103.2M | $96.6M | $91.3M | $107.8M | $124.4M | $150.9M | $152.6M | $160.2M | $129.1M | $197.5M | $60.4M | $8.9M | $8.0M | $6.6M | $5.3M | $5.7M | $2.3M | $3.0M | $2.4M | $3.4M | $3.1M | $3.5M | $5.5M | ||
| Assets Current | $507.4M | $428.7M | $416.8M | $326.5M | $399.1M | $386.5M | $549.9M | $528.3M | $580.7M | $696.6M | $675.2M | $765.3M | $622.8M | $566.7M | $659.1M | $195.6M | $41.2M | $37.0M | $39.2M | $34.8M | $36.3M | $41.1M | $38.2M | $36.1M | $32.0M | $34.7M | $33.2M | $17.5M | ||
| Assets | $1.21B | $1.20B | $1.21B | $1.23B | $1.23B | $1.23B | $1.36B | $1.35B | $1.38B | $1.41B | $1.46B | $1.47B | $1.20B | $1.05B | $999.1M | $247.3M | $95.9M | $89.3M | $61.1M | $56.4M | $55.7M | $54.8M | $55.5M | $55.4M | $58.7M | $58.8M | $58.8M | $22.8M | ||
| Accounts Receivable Net Current | $71.2M | $77.2M | $71.5M | $57.3M | $56.6M | $52.1M | $49.3M | $34.8M | $43.5M | $104.2M | $133.3M | $160.3M | $120.8M | $148.6M | $216.5M | $90.7M | $13.9M | $6.4M | $5.3M | $5.5M | $4.6M | $6.1M | $5.1M | $5.0M | $3.6M | $4.2M | $4.6M | $4.4M | ||
| Accounts Payable Current | $18.1M | $18.9M | $18.2M | $19.8M | $19.9M | $19.6M | $15.8M | $20.6M | $22.1M | $14.5M | $37.1M | $23.7M | $24.9M | $14.7M | $17.4M | $18.7M | $3.6M | $2.9M | $2.2M | $1.2M | $1.5M | $1.0M | $1.8M | $1.3M | $2.4M | $1.8M | $2.3M | $3.3M | ||
| Common Stock Value | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $1.0K | ||
| Other Assets Noncurrent | $23.2M | $23.3M | $32.7M | $39.0M | $32.1M | $32.7M | $38.1M | $49.1M | $45.3M | $61.0M | $61.8M | $34.8M | $8.9M | $8.9M | $5.3M | $975.0K | $80.0K | $160.0K | $409.0K | $167.0K | $231.0K | $18.0K | $20.0K | $30.0K | $71.0K | $61.0K | $69.0K | |||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $6.8M | $6.0M | $4.3M | $9.2M | -$877.0K | -$1.1M | -$16.9M | -$20.7M | -$17.2M | -$25.6M | -$22.4M | -$12.5M | -$212.0K | -$265.0K | -$216.0K | $607.0K | $1.0M | -$193.0K | $179.0K | $203.0K | $95.0K | -$57.0K | -$82.0K | -$87.0K | $10.0K | -$68.0K | -$85.0K | |||
| Accrued Liabilities Current | $23.0M | $21.7M | $16.7M | $23.9M | $26.4M | $25.9M | $21.0M | $22.2M | $21.1M | $25.1M | $27.1M | $11.8M | $5.5M | $1.8M | $2.0M | $1.6M | $1.3M | $1.4M | $1.2M | $1.2M | $1.1M | $781.0K | $902.0K | $745.0K | $471.0K | |||||
| Additional Paid In Capital Common Stock | $565.7M | $550.6M | $543.9M | $532.9M | $522.4M | $511.3M | $514.3M | $506.1M | $496.0M | $477.8M | $504.1M | $507.0M | $483.7M | $482.3M | $450.9M | $201.8M | $148.1M | $146.9M | $117.5M | $115.5M | $114.8M | $113.6M | $113.0M | $112.4M | $111.3M | |||||
| Gain Loss On Disposition Of Assets | $2.0K | -$183.0K | $179.0K | -$250.0K | -$223.0K | -$51.0K | ||||||||||||||||||||||||
| Other Liabilities Noncurrent | $7.6M | $5.9M | $6.1M | $11.8M | $14.4M | $13.9M | $15.8M | $16.6M | $16.1M | $20.0M | $21.7M | $9.7M | $6.6M | $1.2M | $513.0K | $11.0K | $9.0K | $6.0K | $5.0K | $2.0K | ||||||||||
| Available For Sale Securities Debt Securities Noncurrent | $411.8M | $484.5M | $494.1M | $602.2M | $526.2M | $540.5M | $383.7M | $388.4M | $366.8M | $346.9M | $415.6M | $493.2M | $407.3M | $393.3M | $287.6M | $29.0M | $45.4M | $43.3M | $11.5M | $11.7M | $9.0M | $4.3M | ||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $12.1M | -$42.8M | -$13.3M | $188.2M | $64.0M | -$2.7M | -$1.4M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investing Cash Flow * | $111.4M | -$58.4M | $38.9M | -$261.3M | -$546.5M | -$326.4M | -$29.0M | $950.0K | -$2.0M | -$42.8M | -$2.2M | -$780.0K |
| Operating Cash Flow * | -$101.6M | $21.1M | $27.0M | $253.5M | $538.6M | $140.6M | $5.5M | -$675.0K | $1.3M | $4.4M | -$969.0K | -$4.4M |
| Payments To Acquire Property Plant And Equipment | $22.6M | $40.3M | $22.2M | $18.8M | $23.8M | $35.1M | $1.2M | $2.3M | $2.9M | $3.8M | $2.1M | $731.0K |
| Increase Decrease In Accounts Receivable | $23.3M | $16.3M | -$2.4M | -$68.6M | -$42.3M | $178.5M | $839.0K | $2.0M | -$214.0K | $2.3M | $1.8M | $416.0K |
| Increase Decrease In Accounts Payable | $550.0K | $3.1M | -$6.9M | -$25.3M | -$12.2M | $22.6M | -$329.0K | $102.0K | -$363.0K | $1.1M | $132.0K | $150.0K |
| Share Based Compensation | $39.6M | $44.5M | $42.9M | $32.6M | $15.9M | $8.2M | $3.2M | $2.3M | $2.1M | $4.7M | $8.2M | |
| Net Cash Provided By Used In Financing Activities | -$14.8M | -$4.8M | -$47.8M | -$77.1M | $85.4M | $261.3M | $28.8M | $15.0K | -$770.0K | $45.8M | $3.5M | $4.0M |
| Payments To Acquire Marketable Securities | $80.8M | $472.4M | $491.9M | $418.0M | $710.5M | $324.4M | $52.1M | $24.2M | $11.7M | $39.0M | ||
| Proceeds From Sale And Maturity Of Marketable Securities | $211.0M | $349.8M | $508.6M | $232.5M | $83.8M | $19.9M | $24.4M | $28.0M | $11.2M | |||
| Adjustments Related To Tax Withholding For Share Based Compensation | $3.0M | $2.9M | $2.7M | $1.8M | $4.2M | $62.0K | $21.0K | |||||
| Increase Decrease In Other Operating Assets | -$798.0K | -$199.0K | $3.3M | -$9.4M | -$7.8M | $21.1M | -$374.0K | -$91.0K | ||||
| Proceeds From Stock Options Exercised | $1.0K | $51.0K | $3.0K | $31.0K | $86.0K | $104.0K | $38.0K | $15.0K | $31.0K | |||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $105.0K | -$55.0K | -$149.0K | -$453.0K | $34.0K | $20.0K | -$17.0K | -$44.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q1 2020 | Q1 2019 | Q1 2018 | Q1 2017 | Q1 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investing Cash Flow * | $27.7M | -$47.2M | -$4.4M | $688.0K | -$216.5M | -$3.9M | -$2.5M | $51.0K | -$1.9M | -$177.0K | ||||||||||
| Operating Cash Flow * | -$4.4M | $7.3M | -$7.9M | $188.4M | $233.2M | $1.4M | $1.1M | -$1.3M | $1.5M | $875.0K | ||||||||||
| Payments To Acquire Property Plant And Equipment | $4.7M | $4.1M | $2.0M | $5.4M | $11.5M | $796.0K | $134.0K | $1.1M | $90.0K | $177.0K | ||||||||||
| Increase Decrease In Accounts Receivable | $4.5M | -$1.5M | -$9.3M | $32.9M | $34.6M | -$104.0K | -$1.4M | $713.0K | $237.0K | $676.0K | ||||||||||
| Increase Decrease In Accounts Payable | -$658.0K | -$245.0K | -$1.9M | $2.1M | -$6.3M | $1.9M | $79.0K | $218.0K | -$241.0K | $379.0K | ||||||||||
| Share Based Compensation | $10.6M | $11.5M | $10.3M | $5.6M | $3.0M | $924.0K | $583.0K | $545.0K | $565.0K | $1.6M | ||||||||||
| Net Cash Provided By Used In Financing Activities | -$11.2M | -$2.8M | -$1.1M | -$934.0K | $47.3M | -$164.0K | $4.0K | $2.0K | -$801.0K | |||||||||||
| Payments To Acquire Marketable Securities | $195.7M | $143.9M | $130.1M | $219.5M | $8.0M | $6.0M | $4.7M | $2.8M | ||||||||||||
| Proceeds From Sale And Maturity Of Marketable Securities | $32.4M | $95.5M | $141.4M | $27.8M | $14.5M | $4.9M | $3.6M | $5.9M | $1.0M | |||||||||||
| Adjustments Related To Tax Withholding For Share Based Compensation | $357.0K | $345.0K | $1.9M | $431.0K | $544.0K | $1.7M | $517.0K | $232.0K | $869.0K | $522.0K | $436.0K | $494.0K | $2.9M | $39.0K | $513.0K | $46.0K | ||||
| Increase Decrease In Other Operating Assets | -$804.0K | $24.0K | $1.6M | -$3.0M | $9.1M | $924.0K | -$64.0K | $125.0K | ||||||||||||
| Proceeds From Stock Options Exercised | $16.0K | $44.0K | $12.0K | $4.0K | $2.0K | |||||||||||||||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $11.0K | -$69.0K | $28.0K | $10.0K | -$3.0K | $15.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 30.8M | 30.2M | 29.8M | 30.1M | 29.4M | 22.7M | 18.7M | 18.0M | ||
| Weighted Average Number Of Diluted Shares Outstanding | 30.8M | 30.2M | 29.8M | 31.0M | 31.0M | 24.1M | 18.7M | 18.0M | ||
| Common Stock Shares Authorized | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 200.0M |
| Preferred Stock Shares Authorized | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Stock Shares Outstanding | 31.1M | 30.8M | 29.7M | 29.4M | 30.2M | 28.2M | 21.5M | 18.2M | 17.8M | 17.7M |
| Common Stock Shares Issued | 34.5M | 33.6M | 32.4M | 31.2M | 30.2M | 28.2M | 21.5M | 18.2M | 17.8M | 17.7M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 30.7M | 30.5M | 30.8M | 30.4M | 30.1M | 29.8M | 30.0M | 29.8M | 29.5M | 30.2M | 30.4M | 30.2M | 29.7M | 29.2M | 28.8M | 22.1M | 21.7M | 21.6M | 18.5M | 18.3M | 18.2M | 18.0M | 17.9M | 17.9M | 17.8M | 17.7M | 17.7M | 12.8M | 12.4K | 12.1M |
| Weighted Average Number Of Diluted Shares Outstanding | 30.7M | 30.5M | 30.8M | 30.4M | 30.1M | 29.8M | 30.0M | 29.8M | 29.5M | 30.9M | 31.2M | 31.2M | 31.2M | 30.8M | 30.8M | 23.5M | 22.9M | 21.6M | 19.5M | 19.0M | 18.2M | 18.0M | 17.9M | 17.9M | 17.8M | 17.7M | 18.2M | 12.8M | 12.4K | 12.1M |
| Common Stock Shares Authorized | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 200.0M | 200.0M | ||
| Preferred Stock Shares Authorized | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | ||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||
| Common Stock Shares Outstanding | 30.9M | 30.6M | 30.6M | 30.5M | 30.3M | 29.9M | 30.0M | 29.9M | 29.7M | 29.7M | 30.3M | 30.3M | 29.8M | 29.5M | 29.0M | 23.3M | 21.8M | 21.7M | 18.7M | 18.4M | 18.3M | 18.1M | 18.0M | 17.9M | 17.8M | 17.7M | 17.7M | 12.8M | ||
| Common Stock Shares Issued | 34.3M | 34.0M | 33.9M | 33.3M | 33.0M | 32.7M | 31.9M | 31.7M | 31.5M | 30.7M | 30.5M | 30.3M | 29.8M | 29.5M | 29.0M | 23.3M | 21.8M | 21.7M | 18.7M | 18.4M | 18.3M | 18.1M | 18.0M | 17.9M | 17.8M | 17.7M | 17.7M | 12.8M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $39.6M | $44.5M | $42.9M | $32.6M | $15.9M | $8.2M | $3.2M | $2.3M | $2.1M | |||
| Stock Issued During Period Value Stock Options Exercised | $1.0K | $51.0K | $3.0K | $31.0K | $86.0K | $104.0K | $38.0K | $15.0K | $31.0K | |||
| Provision For Doubtful Accounts | $7.6M | -$1.7M | -$880.0K | $32.6M | $8.9M | $1.2M | $189.0K | $309.0K | $160.0K | $76.0K | $48.0K | $33.0K |
| Interest And Other Income | $21.4M | $5.5M | $1.3M | $1.5M | $837.0K | $434.0K | ||||||
| Other Noncash Income Expense | -$30.0K | $7.0K | $21.0K | $11.0K | $15.0K | -$8.0K | -$52.0K | -$44.0K | $15.0K | |||
| Interest And Other Income Expense | $434.0K | $481.0K | -$5.4M | $27.0K | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 | Q3 2016 | Q2 2016 | Q1 2016 | Q4 2015 | Q3 2015 | Q1 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $9.7M | $10.0M | $10.6M | $10.9M | $11.6M | $11.5M | $10.9M | $10.3M | $10.3M | $9.0M | $8.0M | $5.6M | $4.4M | $3.5M | $3.0M | $3.2M | $1.1M | $924.0K | $951.0K | $737.0K | $583.0K | $588.0K | $573.0K | $545.0K | $565.0K | |||||||||||||
| Stock Issued During Period Value Stock Options Exercised | $3.0K | $3.0K | $16.0K | $17.0K | $24.0K | $44.0K | $62.0K | $28.0K | $12.0K | $16.0K | $5.0K | $4.0K | $1.0K | $7.0K | $2.0K | $2.0K | ||||||||||||||||||||||
| Provision For Doubtful Accounts | $2.1M | -$2.5M | -$2.3M | -$2.0M | -$113.0K | $6.5M | $7.2M | $11.6M | $848.0K | $2.2M | $1.1M | $121.0K | $48.0K | |||||||||||||||||||||||||
| Interest And Other Income | $7.7M | $7.6M | $6.6M | $5.1M | $3.8M | $1.4M | $958.0K | $45.0K | $496.0K | $604.0K | $282.0K | $589.0K | $421.0K | $275.0K | $241.0K | $249.0K | $189.0K | $192.0K | $207.0K | $98.0K | $143.0K | $98.0K | $95.0K | |||||||||||||||
| Other Noncash Income Expense | -$21.0K | $12.0K | -$15.0K | $8.0K | $42.0K | $28.0K | -$28.0K | |||||||||||||||||||||||||||||||
| Interest And Other Income Expense | $207.0K | $98.0K | $143.0K | $98.0K | $95.0K | $97.0K | $145.0K | $120.0K | $119.0K | $57.0K | $5.0K | -$5.5M | $13.0K | $7.0K | $0.00 | $20.0K |
Most recent annual filing with the SEC: February 27, 2026
Data sourced from SEC EDGAR public filings as of August 7, 2026.